InsiderTrades

Form 4 for KNSA Kiniksa Pharmaceuticals International, plc

Accepted 2025-04-16 00:00:00 ET · period of report 2025-04-14 · accession 0001415889-25-010808 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-04-16 2025-04-14 KNSA Tessari Eben COO M - OptEx $3.80 +7,000 89.4K +8% +$26.6K
DM 2025-04-16 2025-04-14 KNSA Tessari Eben COO S - Sale+OE $20.48 -12.0K 77.4K -13% -$245.8K
D 2025-04-16 2025-04-14 KNSA Tessari Eben COO M - OptEx $0.00 -7,000 7,049 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Ordinary Share 2025-04-14 M A 7,000 $3.80 89,363 D — —
2 Common Class A Ordinary Share 2025-04-14 S D 5,579 $20.19 83,784 D — — (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $19.54 and $20.535. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
3 Common Class A Ordinary Share 2025-04-14 S D 6,421 $20.74 77,363 D — — (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $20.55 and 20.90. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
4 Derivative Share Option 2025-04-14 M D 7,000 $0.00 7,049 D $3.80 · — to 2027-06-28 7,000 Class A Ordinary Share (F4) The option is fully vested and exercisable.